1. Home
  2. APGE vs CXM Comparison

APGE vs CXM Comparison

Compare APGE & CXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APGE
  • CXM
  • Stock Information
  • Founded
  • APGE 2022
  • CXM 2009
  • Country
  • APGE United States
  • CXM United States
  • Employees
  • APGE N/A
  • CXM N/A
  • Industry
  • APGE Biotechnology: Biological Products (No Diagnostic Substances)
  • CXM Computer Software: Prepackaged Software
  • Sector
  • APGE Health Care
  • CXM Technology
  • Exchange
  • APGE Nasdaq
  • CXM Nasdaq
  • Market Cap
  • APGE 2.4B
  • CXM 2.1B
  • IPO Year
  • APGE 2023
  • CXM 2021
  • Fundamental
  • Price
  • APGE $66.64
  • CXM $7.15
  • Analyst Decision
  • APGE Strong Buy
  • CXM Hold
  • Analyst Count
  • APGE 9
  • CXM 12
  • Target Price
  • APGE $97.33
  • CXM $9.92
  • AVG Volume (30 Days)
  • APGE 730.3K
  • CXM 1.3M
  • Earning Date
  • APGE 11-10-2025
  • CXM 12-03-2025
  • Dividend Yield
  • APGE N/A
  • CXM N/A
  • EPS Growth
  • APGE N/A
  • CXM 163.85
  • EPS
  • APGE N/A
  • CXM 0.45
  • Revenue
  • APGE N/A
  • CXM $820,768,000.00
  • Revenue This Year
  • APGE N/A
  • CXM $6.11
  • Revenue Next Year
  • APGE N/A
  • CXM $5.48
  • P/E Ratio
  • APGE N/A
  • CXM $15.79
  • Revenue Growth
  • APGE N/A
  • CXM 6.08
  • 52 Week Low
  • APGE $26.20
  • CXM $6.75
  • 52 Week High
  • APGE $67.66
  • CXM $9.69
  • Technical
  • Relative Strength Index (RSI)
  • APGE 73.22
  • CXM 37.46
  • Support Level
  • APGE $61.81
  • CXM $7.32
  • Resistance Level
  • APGE $67.66
  • CXM $7.62
  • Average True Range (ATR)
  • APGE 3.73
  • CXM 0.18
  • MACD
  • APGE 0.19
  • CXM -0.04
  • Stochastic Oscillator
  • APGE 91.78
  • CXM 34.19

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

About CXM Sprinklr Inc.

Sprinklr Inc is engaged in enabling customer-facing teams, from Customer Service to Marketing, to collaborate across internal silos, communicate across digital channels, and leverage AI to deliver customer experiences at scale all on one unified AI-based platform. It focuses on empowering companies to deliver next-generation, unified engagement journeys that reimagine the customer's experience. Its products include Sprinklr Service, Sprinklr Social, Sprinklr Insights and Sprinklr Marketing. The company operates in the Americas, EMEA, and other countries. It derives maximum revenue from the Americas.

Share on Social Networks: